Clearside Biomedical
CLSD
CLSD
80 hedge funds and large institutions have $211M invested in Clearside Biomedical in 2018 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 28 increasing their positions, 10 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
48% more funds holding
Funds holding: 54 → 80 (+26)
12.9% more ownership
Funds ownership: 48.65% → 61.55% (+13%)
Holders
80
Holding in Top 10
–
Calls
$1.04M
Puts
$301K
Top Buyers
| 1 | +$17.8M | |
| 2 | +$16.4M | |
| 3 | +$14.7M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
+$6.88M |
| 5 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
+$6.22M |
Top Sellers
| 1 | -$6.61M | |
| 2 | -$1.88M | |
| 3 | -$1.87M | |
| 4 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$644K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
-$342K |